Keyphrases
Non-coding RNA (ncRNA)
100%
Stemness
100%
Glioma Stem Cells
100%
Radiation Response
100%
Tumor Cell Proliferation
100%
TALNEC2
100%
Glioblastoma
55%
E2F Transcription Factor 1 (E2F1)
33%
MicroRNA
33%
Mesenchymal Transformation
33%
Long Non-coding RNA (LncRNA)
22%
Survivors
11%
Sigma Phase
11%
Cell Proliferation
11%
Cell Cycle Progression
11%
Novel Therapeutics
11%
Molecular Mechanism
11%
Cell Cycle-dependent
11%
RNA Sequencing (RNA-seq)
11%
Median Survival
11%
Tumor
11%
Glioma Cells
11%
Self-renewal
11%
Poor Prognosis
11%
Stem Cell-derived
11%
Patient Survival
11%
Therapeutic Target
11%
Array Analysis
11%
Cancer Cell Lines
11%
Prolonged Survival
11%
Cell-derived Xenograft
11%
Novel lncRNA
11%
MiR-191
11%
MicroRNA-21 (miR-21)
11%
Short-term Survival
11%
Tumorigenic Potential
11%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Long Non-Coding RNA
100%
Tumor Progression
100%
E2F1
50%
Cell Cycle
33%
RNA Sequencing
16%
MicroRNA
16%
Cancer Cell
16%
Cell Cycle Progression
16%
Cell Proliferation
16%
Mouse
16%
S Phase
16%
Short Term Survival
16%
Neuroscience
Long Non-Coding RNA
100%
Stem Cell
100%
Cell Growth
100%
E2F1
50%
MicroRNA
50%
Cell Cycle
33%
Cell Line
16%
RNA-Seq
16%
Cell Proliferation
16%
Cell Cycle Progression
16%
Immunology and Microbiology
Glioma Stem Cell
100%
Tumor Cell
100%
Cell Growth
100%
Cell Cycle
33%
Xenograft
16%
RNA Sequencing
16%
Mouse
16%
Cell Proliferation
16%
Glioma Cell
16%
Cell Cycle Progression
16%
Cancer Cell Line
16%
Short Term Survival
16%
Cytosol
16%